Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01738581
Other study ID # 0608M91226-2
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date November 2011
Est. completion date June 2015

Study information

Verified date October 2019
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is exploring a new experimental procedure in dystonia called repetitive transcranial magnetic brain stimulation (TMS) combined with rehabilitation. The purpose of the study is to determine whether repetitive TMS is effective as a treatment to reduce symptoms in dystonia as demonstrated by improved motor performance.


Description:

BACKGROUND: Though the etiology of focal hand dystonia (FHD) is uncertain, two primary factors implicated in the development of dystonic symptoms are excessive cortical excitability and impaired sensorimotor processing.

OBJECTIVE: The purpose of this study was to determine the functional efficacy and neural effects of a Dual intervention of rTMS and sensorimotor retraining. Our working hypothesis is: subjects receiving the combined intervention will (1) display significantly improved handwriting measures; (2) report significant improvement in daily functional ability; (3) display reduced hand cramping compared; and (4) demonstrate reduced corticospinal excitability after the Dual intervention when compared to the rTMS+ stretching and massage (Sham) intervention.

METHODS: A randomized, single-subject, multiple baseline design with crossover is used for this study that will examine ten subjects with FHD with two interventions: five days of low-frequency 1 Hz rTMS + sensorimotor retraining (Dual intervention) vs. rTMS + stretching and massage (Sham). The rTMS is applied to the premotor cortex at 1 Hz at 90% resting motor threshold for 1200 pulses. For sensorimotor retraining, a subset of the Learning-based Sensorimotor Training program was followed.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Greater than 18 years of age

- Symptoms of focal hand dystonia or writer's cramp

Exclusion Criteria:

- History of seizure or other neurologic disorder

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Repetitive Transcranial Magnetic Stimulation
Applied to the premotor cortex at 1 Hz at 90% resting motor threshold for 1200 pulses.
Behavioral:
Sensorimotor Retraining
For sensorimotor retraining, a subset of the Learning-based Sensorimotor Training program was followed
Non-specific Therapy
A non-specific massage and stretching program directed to the hand, wrist and forearm

Locations

Country Name City State
United States Program in Physical Therapy, University of Minnesota Minneapolis Minnesota
United States University of Minnesota, Program in Physical Therapy Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

References & Publications (3)

Byl NN, Nagajaran S, McKenzie AL. Effect of sensory discrimination training on structure and function in patients with focal hand dystonia: a case series. Arch Phys Med Rehabil. 2003 Oct;84(10):1505-14. — View Citation

Kimberley TJ, Borich MR, Arora S, Siebner HR. Multiple sessions of low-frequency repetitive transcranial magnetic stimulation in focal hand dystonia: clinical and physiological effects. Restor Neurol Neurosci. 2013;31(5):533-42. doi: 10.3233/RNN-120259. — View Citation

Kimberley TJ, Schmidt RL, Chen M, Dykstra DD, Buetefisch CM. Mixed effectiveness of rTMS and retraining in the treatment of focal hand dystonia. Front Hum Neurosci. 2015 Jul 9;9:385. doi: 10.3389/fnhum.2015.00385. eCollection 2015. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change From Baseline in Global Rating of Change at Posttest (Day 5) Symptom severity was assessed using the global rating of change (GROC). For the GROC, participants were asked to identify between one to three functions most impacted by focal hand dystonia. At posttest 1 they were then asked to select a rating of perceived change that represented the level of function compared to baseline. Perceived change consisted of a ±7 point Likert scale (+7= a very great deal better, 0= no change, -7= a very great deal worse). Baseline and Posttest
Secondary Change From Baseline in Arm Dystonia Disability Scale at Posttest (Day 5) The Arm Dystonia Disability Scale (ADDS) is a survey where participants rate task difficulty for activities such as writing, handling utensils, and buttoning on a scale of 1-4 (1 = no difficulty ,4 = not able or marked difficulty). This is a subjective assessment of impairment due to focal hand dystonia. Scores are determined using an equation: total points scored, divided by the maximum possible (23), multiplied by the quotient by 90 and subtract from 90%. Scores range from 0%-90% with higher scores indicating more function. Baseline and Posttest
Secondary Change From Baseline in Sensation at Posttest (Day 5) Examinations included two point discrimination. Two-point discrimination threshold was completed using a Disk-Criminator™. Participants were asked to reply "one" or "two" after each presentation. Static and dynamic stimuli were presented to the index and ring fingers bilaterally, meaning it was presented as a static stimuli or it was slowly swept across the skin (dynamic). Baseline and Posttest
Secondary Change From Baseline in Cortical Silent Period at Posttest (Day 5) Cortical silent period (CSP) testing was completed during an isometric contraction of the target muscle whereby the motor evoked potential is followed by a short duration of electromyographic quiescence. The maximal voluntary contraction for finger abduction was recorded using a custom strain gauge placed around the index finger. Real-time visual feedback was given on a laptop screen to project the force produced by the participant and 20% of the maximum of three trials was calculated and displayed on a target line. For the CSP, participants were asked to contract until the target line was met, then a single transcranial magnetic stimulation pulse was delivered to the motor cortex. Ten trials were collected with a short rest period to prevent fatigue.
CSP duration was calculated in milliseconds (ms). CSP EMG data were first rectified, and then a 10-ms moving average calculation was applied to the data. The onset of the CSP was set as the time point of the delivery of the TM
Baseline and Posttest
Secondary Change From Baseline for Pressure During Hand Writing at Posttest (Day 5) Digitized handwriting was assessed using a computerized tablet (WACOM Co., Ltd., japan) with MovAlyzeR® (Neuroscript LLC, Tempe, AZ) hardware and software. Participants used a custom modified digitized pen (Kiko Software, Netherlands) to write in a self-selected pace and style on the tablet with real-time visual feedback. Writing tasks included "My country tis of thee" at a self-selected pace, repeated eight times. Data were sampled at 215 Hz (resolution: 5080 lpi, accuracy: ±0.01 pressure range: 0-800 g). Writing samples were segmented by points of minimal velocity into single strokes for analysis. Pressure for each stroke was automatically calculated within the software. Baseline and Posttest
Secondary Change From Baseline for Physician Rated Impairment at Posttest (Day 5) Video recordings were made as participants wrote on a pad of paper with pen. Participants were asked to draw a series of 10 loops across the pad of paper followed by "The dog is barking" and their signature, each repeated four times. A physician blinded to participant allocation rated recordings. Scoring criteria were adapted from a standardized writer's cramp rating scale (WCRS) (Wissel et al., 1996), rating pathological flexion or extension at the wrist, fingers and elbow, presence of tremor, dystonic posture, writing speed and latency of dystonic symptoms. Final scores are expressed as a rating listed as a movement score. Baseline and Posttest
Secondary Change From Baseline in Physical Function at Posttest (Day 5) Participants completed the full SF-36 assessment with subsection of interest: "physical functioning". Baseline and Posttest
See also
  Status Clinical Trial Phase
Completed NCT04692285 - Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia Phase 1
Completed NCT00505323 - Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness Phase 1
Terminated NCT03206112 - Loss of Depotentiation in Focal Dystonia
Completed NCT00025701 - EEG and EMG Studies of Hand Dystonia N/A
Completed NCT02334683 - Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia N/A
Completed NCT03797638 - Characterization of Manual Dexterity by Finger Force Manipuladum (FFM) in Patients With Writer's Cramp and in Control Subjects N/A
Terminated NCT01750346 - Acetyl Hexapeptide-8 for Blepharospasm Phase 2
Terminated NCT02106936 - Depotentiation in People With Focal Hand Dystonia N/A
Completed NCT00310414 - fMRI Studies of Task Specificity in Focal Hand Dystonia N/A
Completed NCT00309010 - Neurophysiology of Task-Specificity of Focal Hand Dystonia N/A
Completed NCT03471923 - Non-Motor Features of Cervical Dystonia (CD)
Completed NCT00306865 - Brain Changes in Patients With Focal Hand Dystonia N/A
Completed NCT00411255 - Brain Stimulation to Treat Blepharospasm or Meige Syndrome Phase 2
Terminated NCT00487383 - Brain Changes in Blepharospasm
Recruiting NCT05095740 - Effects of Neuromodulation in Laryngeal Dystonia N/A
Completed NCT00713414 - Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
Completed NCT00942851 - A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm Phase 1/Phase 2
Completed NCT00118586 - Neuropathology of Spasmodic Dysphonia
Completed NCT02326818 - Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity Phase 3
Active, not recruiting NCT02911103 - Deep Brain Stimulation Surgery for Focal Hand Dystonia Phase 1/Phase 2